Stock Research for RGLS

RGLS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

RGLS Stock Chart & Research Data

The RGLS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RGLS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


RGLS Due diligence Resources & Stock Charts

The RGLS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View RGLS Detailed Price Forecast - CNN Money CNN View RGLS Detailed Summary - Google Finance
Yahoo View RGLS Detailed Summary - Yahoo! Finance Zacks View RGLS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View RGLS Trends & Analysis - Trade-Ideas Barrons View RGLS Major Holders - Barrons
NASDAQ View RGLS Call Transcripts - NASDAQ Seeking View RGLS Breaking News & Analysis - Seeking Alpha
Spotlight View RGLS Annual Report - CompanySpotlight.com OTC Report View RGLS OTC Short Report - OTCShortReport.com
TradeKing View RGLS Fundamentals - TradeKing Charts View RGLS SEC Filings - Bar Chart
WSJ View Historical Prices for RGLS - The WSJ Morningstar View Performance/Total Return for RGLS - Morningstar
MarketWatch View the Analyst Estimates for RGLS - MarketWatch CNBC View the Earnings History for RGLS - CNBC
StockMarketWatch View the RGLS Earnings - StockMarketWatch MacroAxis View RGLS Buy or Sell Recommendations - MacroAxis
Bullish View the RGLS Bullish Patterns - American Bulls Short Pains View RGLS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View RGLS Stock Mentions - StockTwits PennyStocks View RGLS Stock Mentions - PennyStockTweets
Twitter View RGLS Stock Mentions - Twitter Invest Hub View RGLS Investment Forum News - Investor Hub
Yahoo View RGLS Stock Mentions - Yahoo! Message Board Seeking Alpha View RGLS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for RGLS - SECform4.com Insider Cow View Insider Transactions for RGLS - Insider Cow
CNBC View RGLS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for RGLS - OTC Markets
Yahoo View Insider Transactions for RGLS - Yahoo! Finance NASDAQ View Institutional Holdings for RGLS - NASDAQ


Stock Charts

FinViz View RGLS Stock Insight & Charts - FinViz.com StockCharts View RGLS Investment Charts - StockCharts.com
BarChart View RGLS Stock Overview & Charts - BarChart Trading View View RGLS User Generated Charts - Trading View




Latest Financial News for RGLS


Do You Know Who Else Invests In Regulus Therapeutics Inc (NASDAQ:RGLS)?
Posted on Wednesday September 19, 2018

The big shareholder groups in Regulus Therapeutics Inc (NASDAQ:RGLS) have power over the company. Institutions will often hold stock in bigger companies, and we expect to see insiders owning aRead More...


These Biotech Stocks Are Moving Higher in August
Posted on Thursday August 23, 2018

GT Biopharma (GTBP) for example, recently announced that the company has a Material Transfer Agreement between a Major Pharmaceutical Company and Dr. Daniel Vallera, Director, Section of Molecular Cancer Therapeutics at the Masonic Cancer Center, University of Minnesota, has brought some attention to the company. Under the terms of the agreement, this Company will supply a formulation of their multibillion-dollar, widely prescribed oncology drug, which has been approved for use in several hematologic malignancies to Dr. Vallera to be used in this study.


Regulus (RGLS) Reports Q2 Loss, Misses Revenue Estimates
Posted on Thursday August 09, 2018

Regulus (RGLS) delivered earnings and revenue surprises of 18.75% and -10.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?


Regulus: 2Q Earnings Snapshot
Posted on Thursday August 09, 2018

The San Diego-based company said it had a loss of 13 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.